Technical events and factor profile →
This 10-Q introduces no material changes to the risk factors vs. the latest annual report.
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | |
|---|---|---|---|---|---|
| Revenue | $8.7B | $8.9B | $9.5B | $9.0B | $9.8B |
| YoY growth | -11.2% | -1.0% | -5.7% | -6.0% | +1.0% |
| Gross margin | — | — | — | — | — |
| Operating margin | 2.7% | -27.8% | 3.7% | 6.8% | -1.9% |
| Net income | $149M | -$2.9B | -$252M | -$148M | $1.6B |
| Diluted EPS | 0.06 | -1.17 | -0.10 | -0.06 | 0.63 |
XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.
Similar than in the previous 10-Q (2026-05-06: -6, -4 points)
10-Q of 2026-08-06 · 13.8% positive sentences, 21.7% negative · 276 sentences analysed
Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.
| Third Point · Dan Loeb
held since Q2 2026 |
11.5% | $533.2M | new |
| Soros Fund Management · George Soros
held since Q4 2025 |
0.7% | $39.7M | +36% |
| Bridgewater Associates · Ray Dalio | — | sold |
Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.
| 2026-09-14 | Locke Lori C. · Officer | Sell | $819K | SEC ↗ |
| 2026-09-11 | FISHER RICHARD W · Director | Sell | $188K | SEC ↗ |
Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.